provided the R,ꢀ-unsaturated aldehyde 14 in 73% overall
yield from 11.
Scheme 2. Synthesis of the R,ꢀ-Unsaturated Aldehyde 14
With the requisite aldehyde 14 in hand, construction of
the oxabicyclo[3.2.1]octene B-ring was pursued (Scheme 3).
Scheme 3. Synthesis of the Framework of Cortistatins
quantitative yield.5 C-alkylation of 7 at the C8-position with
iodide 8 was accomplished under Molander’s conditions
(NaH, DMSO in THF)6 to give indanone 9 in 53% yield;
this was stereoselectively reduced by NiCl2·6H2O and NaBH4
to give the desired trans-fused ketone 10.6a,7 The stereo-
chemistry of 10 was verified by NOESY experiments (see
Supporting Information). Other reductive conditions (H2, Pd/
C; t-BuCuH; or Birch reduction)8 did not give 10 as a major
product.
Regioselective TMS-enol ether formation from 10 fol-
lowed by oxidation under Saegusa conditions9 furnished the
C11,12 double bond. Treatment of enone 11 with lithium
diisopropylamide and triflic anhydride resulted in the forma-
tion of dienyl triflate 12, which underwent Pd-catalyzed
methoxycarbonylation to give methyl ester 13.10 Finally,
DIBAL reduction and subsequent Dess-Martin oxidation11
Treatment of 14 with cyclohexane-1,3-dione (4) (1.5 equiv)
in the presence of piperidine (1.1 equiv) in EtOAc (15 mM)
for 6 h produced the desired pyran 16 along with its C8-
epimer as a 5:1 mixture in one pot (87% combined yield).
Knoevenagel reaction between 14 and 4 gave the condensed
product 15, which underwent spontaneous electrocyclization
to give 16 as a major product.12 Selective TBS removal of
the primary alcohol, without affecting the secondary one,
using HF·pyridine gave 17, which was treated with I2, Ph3P,
and imidazole13 to afford iodide 18 in 87% overall yield (10:1
diastereomeric mixture). Interestingly, when 18 was kept at
-30 °C for 12 h, it crystallized, and the 18/C8-epimer ratio
increased to 20:1, as confirmed by NMR in CDCl3. However,
the ratio changed to 7:1 when the mixture was kept for 1 h
in CDCl3, and then became 5:1 after 7 h at room temperature.
(4) Hajos, Z. G.; Parrish, D. R. J. Org. Chem. 1974, 39, 1615.
(5) (a) Micheli, R. A.; Hajos, Z. G.; Cohen, N.; Parrish, D. R.; Portland,
L. A.; Sciamanna, W.; Scott, M. A.; Wehrli, P. A. J. Org. Chem. 1975, 40,
675. (b) Gardner, J. N.; Anderson, B. A.; Oliveto, E. P. J. Org. Chem.
1969, 34, 107.
(6) (a) Molander, G. A.; Quirmbach, M. S.; Silva, L. F.; Spenver, K. C.,
Jr.; Balsells, J. Org. Lett. 2001, 3, 2257. (b) Hajos, Z. G.; Parrish, D. R.;
Oliveto, E. P. Tetrahedron 1968, 24, 2039.
(10) Cacchi, S.; Morera, E.; Ortar, G. Tetrahedron Lett. 1985, 26, 1109.
(11) Dess, D. B.; Martin, J. C. J. Org. Chem. 1983, 48, 4155.
(12) For a recent review for constructing 1-oxadecalin, see: Tang, Y.;
Oppenheimer, J.; Song, Z.; You, L.; Zhang, X.; Hsung, R. P. Tetrahedron
2006, 62, 10785.
(7) For a general review, see: (a) Ganem, B.; Osby, J. O. Chem. ReV.
1986, 86, 763. (b) Shigehisa, H.; Mizutani, T.; Tosaki, S.; Ohshima, T.;
Shibasaki, M. Tetrahedron 2005, 61, 5057
.
(8) For a review, see: (a) Jankowski, P.; Marczak, S.; Wicha, J.
Tetrahedron 1998, 54, 12071.
(13) Garegg, P. J.; Samuelsson, B. J. Chem. Soc., Chem. Commun. 1979,
978.
(9) Ito, Y.; Hirao, T.; Saegusa, T. J. Org. Chem. 1978, 43, 1011.
3414
Org. Lett., Vol. 10, No. 16, 2008